DealForma
Depends
Confidence: Medium
Buy if you're a biopharma BD, corp-dev, or investment team needing curated licensing, M&A, and venture comps.
Comparison
DealForma and AlphaSense both land on Depends.
Buy if you're a biopharma BD, corp-dev, or investment team needing curated licensing, M&A, and venture comps.
Buy if you run investment research or competitive intelligence at a bank, fund, or large enterprise with real budget.
| Compare | DealForma | AlphaSense |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Biopharma BD teams | Hedge funds and banks |
| Who it's not for | Anyone outside biopharma . zero coverage elsewhere | Small businesses . five-figure pricing |
| Privacy | No known public vulnerabilities found in the sources reviewed.12 | No known public vulnerabilities found in the sources reviewed. |
| Support quality | Hands-on case studies, but vendor is tiny | 24/5 product experts advertised |
| Public sentiment | Independent reviews are scarce; third-party guides praise its curated biopharma focus and its own site shows strong customer testimonials.³ | Reviewers praise the depth of search but most commonly complain about cost and learning curve. |
| Biggest gotcha | ~$18K individual seat; team pricing likely quote-based . confirm costs before demo³ | Contracts reportedly run five figures annually; get the full quote before signing. |